Access Map
日本語
About KOTAI
Details of our Business
For Ordinary Guests
For Researchers and Medical Professionals
Business Model
Clinical Research
Currently Recruiting
Ongoing and Previous
News
Recruitment
Contact us
About KOTAI
Details of our Business
For Ordinary Guests
For Researchers and Medical Professionals
Business Model
Clinical Research
Currently Recruiting
Ongoing and Previous
News
Recruitment
Contact us
Access Map
News
HOME
News
Information
Jul. 18, 2024
Notice of Office Relocation
Information
Jul. 31, 2023
Notice of acquisition by Sanyo Trading Co., Ltd.
Press Release
Jun. 19, 2023
Update on Antigen Design for Universal Sarbecovirus Vaccine by Shionogi and KOTAI
Press Release
Jun. 30, 2022
Notice Regarding the Inclusion of Universal Antigen Vaccine Research into the Vaccine / New Modality Research and Development Project following a Public Solicitation by SCARDA
Press Release
Sep. 29, 2021
Joint Research on the antigen design for COVID-19 universal vaccines
Press Release
Sep. 01, 2021
Joint research on personalized cancer immunotherapy using regenerated T cells derived from iPS cells
Press Release
Oct. 01, 2020
Joint research on personalized cancer immunotherapy using regenerated T cells derived from iPS cells
Press Release
Aug. 05, 2020
Joint Research on the analysis of immune profile of COVID-19 patients.
Press Release
Mar. 24, 2020
Participation in the Clinical Research on the Coronavirus Disease (COVID-19)
Information
Jan. 06, 2020
KOTAI Biotechnologies, Inc was granted as Japan’s first 10x Certified Service Provider.
1
2
